Drug Profile
Influenza A virus H5N1 vaccine - CSL
Alternative Names: Avian influenza (bird flu) virus vaccine - CSL; CSL-401; CSL444 (Pandemic ISCOMATRIX® Flu); H5N1 aluminium pandemic influenza vaccine - CSL; H5N1 pandemic influenza vaccine - CSL; PanvaxLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator CSL
- Class Influenza A virus H5N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza A virus H5N1 subtype
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-A-virus-H5N1-subtype(Prevention) in New Zealand (Parenteral, Injection)
- 11 Dec 2008 Launched (CSL 401) for Influenza-A virus H5N1 subtype in Australia (Parenteral); first global launch
- 11 Dec 2008 Registered (CSL 401) for Influenza-A virus H5N1 subtype in Singapore (Parenteral)